India Cervical Cancer Screening Market Offers Untapped Opportunities, States Kuick Research in New Report Available at MarketPublishers.com
24 Nov 2016 • by Natalie Aster
LONDON – Not many developing countries can boast execution of population-based cervical cancer screening programs, though cervical cancer is one of the greatest burdens in such countries. This problem is relative to a lack of infrastructure and resources, extreme poverty, and more.
One fourth of the world’s cervical incidences and death belongs to India. The women population accounts around 49% of the total population in this country. When it comes to the female population, women living in urban areas are more aware of the cervical screening than their rural counterparts.
Pap and VIA tests are the most common one when it comes to the screening. Still they have disadvantages: inconvenience, more confirmatory in nature, etc.
The Indian market for cervical cancer screening has not surpassed its infancy stage yet. It is unorganized to a great extent as the tests are performed under public standards or in hospitals.
The demand for cervical cancer screening is expected to grow significantly in the years to come thanks to rising awareness over cancer and growing concerns relative to this disease. There are a limited number of players in the local marketplace, and the competition is low.
No player takes the lead in this market. Newcomers can grab opportunities this marketplace offers, but they will face some entry restraints first. The initial level of investment that is required to set up the operations is the major one.
New research report “India Cervical Cancer Screening Market Outlook 2022” drawn up by Kuick Research offers an in-depth analysis of the cervical cancer screening market in India. The study starts with coverage of the occurrence rate of this disease.
It sheds light on risk factors relative to this disease. The report proceeds with an insightful overview of the Indian cervical cancer screening marketplace. The research study sheds light on therapeutic strategic for this disease’s treatment.
It concentrates on HPV vaccination in this country. The research report looks at vaccination programs and unveils available vaccines. The study also delves into the HPV market dynamics and analyses this marketplace.